COP26 – did Glasgow meet the standard?
Having dominated the headlines for weeks, COP26 has come to an end in Glasgow.
Digital technologies empowering food manufacturers.
As consumer appetite for greater insight into food authenticity grows, manufacturers need to ensure they are prepared so they can offer full transparency and traceability.
Five things we’ve learnt about the future of digital audits.
In 2020, LRQA customers were forced to adopt digital assurance. For many, it was a new and uncertain world.
Ransomware – three questions to ask your cybersecurity teams
In June 2021 it was JBS Foods, the world's largest meat producer and in July it was Swedish retailer Coop – both victims of ransomware attacks attributed to the REvil organisation.
Assurance in the additive manufacturing world.
A growing emphasis on assurance across additive manufacturing reflects an industry entering a new stage on its journey to maturity. Building confidence in AM products is both necessary and increasingly urgent, argues LRQA's Andy Imrie.
Why businesses must re-balance mental and physical health focus.
World Day for Safety and Health at Work 2021 is a much-needed opportunity for employers to give mental well-being the same attention as physical health, writes LRQA's James Pomeroy.
One size does not fit all.
As an expert in supply chain assurance, we have seen first-hand how the scale and pace of change forced on businesses by the COVID-19 pandemic exposed some deep-rooted issues.
ISO/PAS 45005 guidelines for safe working during the pandemic.
The COVID-19 pandemic has completely transformed the world of work. Organizations have had to instantly shift to widespread remote working - requiring them to quickly adapt to face the challenges introduced by a more distributed workforce.
ISO/FDIS 45003: tackling psychological health at work.
The world of work has changed significantly, and many organizations now have a much stronger focus on issues regarding the mental health and well-being of their employees.
Allergen labelling – what’s going on?
Late last year, the FDA warned two major US firms for ‘repeat offenses’ of product labels not specifying allergens. Two letters do not constitute a trend, but I was reminded of these incidents recently, as I read our monthly intelligence reports.